This program is currently seeking patients with a diagnosis of Mild Cognitive Impairment or early Alzheimer's disease who are interested in joining a therapy (drug) trial. Patients are assessed to determine their likely eligibility for trials accepting new patients in Melbourne Victoria, and referred to these trials as appropriate.
Assessment in this program includes:
- Review of medical history
- Blood tests
- Memory and thinking tests
- Brain scans (2 PET scans and 1 MRI)